Aarestrup F M, Kruse H, Tast E, Hammerum A M, Jensen L B
Danish Veterinary Laboratory, Copenhagen.
Microb Drug Resist. 2000 Spring;6(1):63-70. doi: 10.1089/mdr.2000.6.63.
This study compares the susceptibility of Enterococcus faecium isolated from pigs and poultry in Denmark, Finland, and Norway to antimicrobial agents used for growth promotion. E. faecium was isolated from 211 broilers and 55 pigs in Denmark in 1997, from Norwegian 55 poultry farms (turkey and broiler farms) and 4 swine farms between 1995 and 1997, and Finnish poultry (52) and swine (43) in 1996 and examined for susceptibility to avilamycin, avoparcin, bacitracin, flavomycin, monensin, salinomycin, spiramycin, tylosin, and virginiamycin. Only a limited number of isolates were categorized as resistant to monensin or salinomycin. In general, an association between the usage of antimicrobial agents in the respective countries and the occurrence of associated resistance was observed. Resistance to avilamycin was frequently observed among isolates from broilers in Denmark, where avilamycin has been used, whereas all isolates from Finland and Norway, where these drugs have not been used, were susceptible. The same phenomenon could be observed for avoparcin, bacitracin, tylosin, and virginiamycin; resistance was frequently observed among isolates from where these antimicrobials have been widely used, but rarely among isolates from where the use has been limited. Also for avoparcin and bacitracin, an association between usage and occurrence of resistance was observed. All isolates categorized as avoparcin resistant contained the vanX gene; isolates from broilers had the T variant in position 8,234 and isolates from pigs the G variant. Three (1%) of the 222 isolates resistant to tylosin contained the ermA gene and 196 (88%) ermB. Sixteen (11%) of the 146 virginiamycin-resistant isolates from broilers and two (7%) of the 27 virginiamycin-resistant isolates from pigs in Denmark contained the satA gene, whereas satA was not observed among any of the virginiamycin-resistant isolates from Finland. A total of 72% of the virginiamycin-resistant E. faecium from broilers in Denmark and all nine virginiamycin-resistant E. faecium from Finland contained satG. This gene was also observed among two (7%) of the virginiamycin-resistant isolates from pigs in Denmark. This study indicates that the use of antimicrobial agents for growth promotion in Denmark, Finland, and Norway have selected for resistance to most of these drugs among E. faecium in food animals.
本研究比较了从丹麦、芬兰和挪威的猪和家禽中分离出的屎肠球菌对用于生长促进的抗菌药物的敏感性。1997年从丹麦的211只肉鸡和55头猪中分离出屎肠球菌,1995年至1997年从挪威的55个家禽养殖场(火鸡和肉鸡养殖场)和4个养猪场中分离出屎肠球菌,1996年从芬兰的家禽(52只)和猪(43头)中分离出屎肠球菌,并检测其对阿维拉霉素、阿伏帕星、杆菌肽、黄霉素、莫能菌素、盐霉素、螺旋霉素、泰乐菌素和维吉尼亚霉素的敏感性。只有少数分离株被归类为对莫能菌素或盐霉素耐药。总体而言,观察到各个国家抗菌药物的使用与相关耐药性的发生之间存在关联。在丹麦使用过阿维拉霉素的肉鸡分离株中经常观察到对阿维拉霉素的耐药性,而在未使用过这些药物的芬兰和挪威,所有分离株均敏感。阿伏帕星、杆菌肽、泰乐菌素和维吉尼亚霉素也观察到同样的现象;在广泛使用这些抗菌药物的地区的分离株中经常观察到耐药性,而在使用有限的地区的分离株中则很少见。对于阿伏帕星和杆菌肽,也观察到使用与耐药性发生之间的关联。所有被归类为对阿伏帕星耐药的分离株都含有vanX基因;肉鸡分离株在8234位有T变体,猪分离株有G变体。222株对泰乐菌素耐药的分离株中有3株(1%)含有ermA基因,196株(88%)含有ermB基因。丹麦146株对维吉尼亚霉素耐药的肉鸡分离株中有16株(11%)和27株对维吉尼亚霉素耐药的猪分离株中有2株(7%)含有satA基因,而在芬兰的任何对维吉尼亚霉素耐药的分离株中均未观察到satA基因。丹麦肉鸡中72%的对维吉尼亚霉素耐药的屎肠球菌和芬兰所有9株对维吉尼亚霉素耐药的屎肠球菌都含有satG基因。在丹麦猪的2株对维吉尼亚霉素耐药的分离株中(7%)也观察到了该基因。本研究表明,丹麦、芬兰和挪威将抗菌药物用于生长促进已导致食用动物中的屎肠球菌对这些药物中的大多数产生耐药性。